Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques
Authors:
- Sabrina BentonSBSabrina Benton
- Geert van AmerongenGAGeert van Amerongen
- Koert J. StittelaarKSKoert J. Stittelaar
- Albert D.M.E. OsterhausAOAlbert D.M.E. Osterhaus
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Protection of Rhesus Monkeys against Dengue Virus Challenge after Tetravalent Live Attenuated Dengue Virus VaccinationThe Journal of Infectious Diseases, 2006
- Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults☆Vaccine, 2006
- PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINEThe American Journal of Tropical Medicine and Hygiene, 2003
- Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersVaccine, 2001
- Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesisFEMS Immunology & Medical Microbiology, 2000
- Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccinesVaccine, 1999
- Antibody, Macrophages, Dengue Virus Infection, Shock, and Hemorrhage: A Pathogenetic CascadeClinical Infectious Diseases, 1989
- Pathogenesis of Dengue: Challenges to Molecular BiologyScience, 1988
- Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibodyJournal of Experimental Medicine, 1977
- Antibody-enhanced dengue virus infection in primate leukocytesNature, 1977